Scientists test radiation 'One-Two Punch' to rally Body's defenses against liver cancer
NCT ID NCT04605731
Summary
This early-stage study is testing the safety and effectiveness of a two-step treatment for advanced liver cancer that cannot be surgically removed. First, patients receive a targeted radiation treatment directly to the liver tumor. Then, they receive two immunotherapy drugs designed to help the body's own immune system find and fight the cancer cells. The study will enroll about 25 patients to see if this combination is safe and if it helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.